View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
January 22, 2020updated 13 Feb 2020 10:27am

Coronavirus: CDC confirms first US case; search for cure underway

The Centers for Disease Control and Prevention (CDC) in the US has reported the first case of the new coronavirus, named 2019-nCoV, in a man who returned from Wuhan city of China to Washington.


Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Free Report
img

What is the Global Healthcare and Pharma Market Q2 Outlook?

Given the background of high inflation, re-emerging supply chain issues, and the widespread macro-economic implications of the Ukraine conflict, the global pharmaceutical industry is facing an entirely new set of challenges following the turbulence of the COVID-19 pandemic. GlobalData’s World Markets Healthcare (WMH) service has released its latest Q2 forecast. This report incorporates the latest thinking on the opportunities and risks this new environment presents for pharma companies. However, the pharma sector is proving resilient, and we are projecting 4.4% global growth for the year ahead. Yet it remains that the current economic picture is inverting some baseline assumptions from previous quarterly forecasts and altering which markets we expect the key growth levers to derive from. Download our latest executive summary for a snapshot view of what our clients use to formulate winning strategies.
by GlobalData
Enter your details here to receive your free Report.

Follow the latest updates of the outbreak on our timeline.

The Centers for Disease Control and Prevention (CDC) in the US has reported the first case of the new coronavirus, named 2019-nCoV, in a man who returned from Wuhan city of China to Washington.

The US patient returned to the country on 15 January, with infection confirmation taking place on 21 January. The patient is assumed to be relatively healthy, now isolated at a medical centre as a precaution.

Following the report, the Dow and broader stock market saw a drop in the stock.

While the risk to the general public is low, US officials have been preparing to address a potential outbreak in the country.

In addition to alerting clinicians and screening at airports, CDC is developing a diagnostic test to identify the virus in clinical specimens. The organisation intends to share the tests to partners globally in the coming weeks.

On 16 January, the German Center for Infection Research (DZIF) at Charité – Universitätsmedizin Berlin researchers announced the development of the first diagnostic assay to detect the virus. The laboratory test has been made publicly available and is in a joint evaluation study by an international consortium.

Coronavirus symptoms are similar to those caused by flu, such as pneumonia. The virus has been linked to a seafood market in Wuhan, where the outbreak began. Death toll from the virus has increased to nine as of 21 January, said Chinese officials.

Alongside China, cases of the new coronavirus have been reported in Thailand, Japan and Korea. On 21 January, Taiwan reported the first case of coronavirus infection in a woman who returned from Wuhan.

Related Companies

Free Report
img

What is the Global Healthcare and Pharma Market Q2 Outlook?

Given the background of high inflation, re-emerging supply chain issues, and the widespread macro-economic implications of the Ukraine conflict, the global pharmaceutical industry is facing an entirely new set of challenges following the turbulence of the COVID-19 pandemic. GlobalData’s World Markets Healthcare (WMH) service has released its latest Q2 forecast. This report incorporates the latest thinking on the opportunities and risks this new environment presents for pharma companies. However, the pharma sector is proving resilient, and we are projecting 4.4% global growth for the year ahead. Yet it remains that the current economic picture is inverting some baseline assumptions from previous quarterly forecasts and altering which markets we expect the key growth levers to derive from. Download our latest executive summary for a snapshot view of what our clients use to formulate winning strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology